GlassScriptPhysician profile
Megan C Weaver
NPI 1457633786
$11,000.78
in general payments reported to CMS, 2019-2025
62 companies · $3,251 in 2025
The $3,251 reported for 2025 was more than what 97% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $334 · 2022: $1,380 · 2023: $3,059 · 2024: $2,978 · 2025: $3,251.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,552 · Education: $735.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,551.92 |
| Education | $734.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $948.53 | 2022-2025 | Imfinzi, Enhertu, Lynparza |
| Novartis Pharmaceuticals Corporation | $922.11 | 2022-2025 | Piqray, Kisqali |
| Merck Sharp & Dohme LLC | $775.90 | 2022-2025 | Keytruda, Welireg, Lynparza |
| Pfizer INC. | $629.57 | 2022-2025 | |
| Gilead Sciences, INC. | $528.15 | 2023-2025 | Trodelvy |
| Incyte Corporation | $469.08 | 2022-2025 | Jakafi, Monjuvi, Zynyz |
| Daiichi Sankyo INC. | $454.45 | 2022-2025 | Enhertu, Injectafer, Datroway |
| E.R. Squibb & Sons, L.L.C. | $415.54 | 2021-2024 | Opdivo, Opdualag |
| Genzyme Corporation | $397.05 | 2021-2025 | |
| Janssen Biotech, INC. | $375.20 | 2022-2025 | Rybrevant, Tecvayli, Darzalex |
| Adaptive Biotechnologies Corporation | $370.26 | 2023-2025 | Clonoseq |
| Seagen INC. | $369.70 | 2021-2025 | Adcetris, Tukysa |
| Amgen INC. | $310.46 | 2022-2023 | Evenity, Lumakras, Xgeva |
| Eisai INC. | $300.91 | 2022-2025 | |
| Astellas Pharma US INC | $289.42 | 2022-2025 | Padcev, Xtandi |
Show all 62 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celgene Corporation | $193.98 | 2022-2025 | Reblozyl |
| Abbvie INC. | $193.80 | 2022-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $181.90 | 2023-2025 | Alunbrig, Fruzaqla, Iclusig |
| Genentech USA, INC. | $170.85 | 2023-2025 | Tecentriq, Polivy, Alecensa |
| Glaxosmithkline, LLC. | $142.56 | 2023-2025 | Zejula, Ojjaara, Blenrep |
| Acrotech Biopharma INC. | $140.38 | 2022-2025 | Beleodaq |
| Lilly USA, LLC | $123.46 | 2022-2025 | Jaypirca, Verzenio, Retevmo |
| Exelixis INC. | $115.32 | 2022-2025 | Cabometyx |
| Jazz Pharmaceuticals INC. | $114.56 | 2022-2025 | |
| Servier Pharmaceuticals LLC | $111.76 | 2023-2025 | |
| Blueprint Medicines Corporation | $110.58 | 2023-2025 | Ayvakit |
| Syndax Pharmaceuticals, INC. | $110.33 | 2025 | Revuforj |
| Regeneron Healthcare Solutions, INC. | $95.74 | 2023-2025 | Libtayo |
| Emd Serono, INC. | $94.75 | 2023-2025 | Tepmetko |
| Coherus Oncology, INC. | $87.90 | 2022-2024 | |
| Array Biopharma INC | $87.42 | 2024-2025 | Braftovi, Lorbrena, Mektovi |
| Genmab U.S., INC. | $86.45 | 2023-2025 | Tivdak, Epkinly |
| Beigene USA, INC. | $83.70 | 2023-2025 | Brukinsa |
| Pharmacyclics LLC, An Abbvie Company | $82.34 | 2021-2023 | Imbruvica, Epkinly |
| Pharmaessentia USA Corporation | $78.67 | 2022-2025 | Besremi |
| Sobi, INC | $75.83 | 2023-2025 | |
| Ipsen Biopharmaceuticals, INC | $72.67 | 2022-2025 | Onivyde, Somatuline Depot |
| Pharmacosmos Therapeutics INC. | $66.57 | 2024-2025 | Monoferric |
| Morphosys, US INC. | $62.97 | 2023 | Monjuvi |
| Geron Corporation | $59.89 | 2025 | Rytelo |
| Puma Biotechnology, INC. | $56.94 | 2022-2025 | |
| Alexion Pharmaceuticals, INC. | $56.59 | 2024 | Ultomiris |
| Bayer Healthcare Pharmaceuticals INC. | $48.94 | 2022-2025 | |
| Janssen Scientific Affairs, LLC | $48.17 | 2023-2024 | Rybrevant |
| Boehringer Ingelheim Pharmaceuticals, INC. | $47.82 | 2024-2025 | |
| Aveo Pharmaceuticals, INC. | $41.88 | 2022-2025 | |
| Taiho Oncology, INC. | $39.60 | 2025 | |
| Caris Mpi, INC. | $35.43 | 2025 | Mi Cancer Seek |
| Octapharma USA, INC. | $35.28 | 2024 | Octagam Immune Globulin (Human) |
| Legend Biotech USA INC. | $34.64 | 2025 | Carvykti |
| Mauna Kea Technologies, INC. | $33.20 | 2023 | |
| Cti Biopharma Corp. | $33.19 | 2022-2023 | Vonjo |
| Tempus Ai, INC | $28.34 | 2024 | |
| Rigel Pharmaceuticals, INC. | $23.36 | 2025 | Gavreto, Tavalisse, Rezlidhia |
| Adc Therapeutics America, INC. | $20.42 | 2023 | |
| Pharming Healthcare, INC. | $19.96 | 2023 | Ruconest |
| Beone Medicines USA, INC. | $19.25 | 2025 | Brukinsa |
| Abbott Laboratories | $19.25 | 2025 | Esprit |
| Stemline Therapeutics INC. | $15.92 | 2023 | Orserdu |
| Agios Pharmaceuticals, INC. | $15.26 | 2023 | Pyrukynd |
| Corcept Therapeutics | $13.83 | 2025 | Korlym |
| Mirati Therapeutics, INC. | $12.80 | 2023 | Krazati |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Megan Weaver listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.